Literature DB >> 30398458

Who adopts a patient portal?: An application of the diffusion of innovation model.

Srinivas Emani1, Ellen Peters2, Sonali Desai3, Andrew S Karson4, Stuart R Lipsitz5, Rajani LaRocca6, John Stone7, Vlas Suric8, Jonathan S Wald9, Amy Wheeler10, Deborah H Williams11, David W Bates12.   

Abstract

BACKGROUND: Patient portals have emerged as an important tool through which patients can access online health information and engage in their health care. However, we know little about how patients perceive portals and whether patient perceptions might influence portal adoption.
OBJECTIVE: Apply the diffusion of innovation (DOI) theory to assess perceptions of adopters and non-adopters of a patient portal.
METHODS: We conducted a cross-sectional survey of adopters and non-adopters of the portal. Our survey consisted of perceived attributes from the DOI theory, socio-demographic characteristics and patient perceptions of technology adoption.
RESULTS: Three factors representing perceived attributes from DOI theory accounted for 73% of the variance in the data: Factor 1 - Relative Advantage (27%); Factor 2 - Ease of Use (24%) and Factor 3 - Trialability (22%). Adopters perceived greater Relative Advantage [mean (SD)] = 3.8 (0.71) versus 3.2 (0.89), p < 0.001, Ease of Use = 4.1 (0.71) versus 3.3 (0.95), p < 0.001 and Trialability = 4.0 (0.57) versus 3.4 (0.99), p < 0.001 than non-adopters. In multivariate modelling, age [OR = 3.75, 95% CI: (2.17, 6.46), p < 0.001] and income [OR = 1.87, 95% CI: (1.17, 3.00), p < 0.01] predicted adoption of the portal. Among DOI factors, Relative advantage predicted adoption of the portal [OR = 1.48, 95% CI: (1.03, 2.11), p < 0.05].
CONCLUSION: Patients will adopt a patient portal if they perceive it to offer a relative advantage over existing practices such as telephoning or visiting the doctor's office. Organisations seeking to increase the adoption of patient portals should implement strategies to promote the relative advantage of portals as, for example, through posters in waiting and exam rooms. A digital divide in the adoption of patient portals may exist with respect to age and income.

Entities:  

Keywords:  Adoption; Diffusion of innovation; Digital divide; Patient portal; Perceptions

Mesh:

Year:  2018        PMID: 30398458     DOI: 10.14236/jhi.v25i3.991

Source DB:  PubMed          Journal:  J Innov Health Inform        ISSN: 2058-4555


  6 in total

1.  Factors Affecting Portal Usage Among Chronically Ill Patients During the COVID-19 Pandemic in the Netherlands: Cross-sectional Study.

Authors:  Qingxia Kong; Danique Riedewald; Marjan Askari
Journal:  JMIR Hum Factors       Date:  2021-07-19

2.  You've Got Mail: a Case-Based Curriculum to Teach Patient E-mail Communication to Internal Medicine Residents.

Authors:  Adam Luxenberg; Leslea Brickner; Stephan Lee; Nirmala D Ramalingam; H Nicole Tran
Journal:  J Gen Intern Med       Date:  2020-07-06       Impact factor: 6.473

3.  The Effect of Persuasive Design on the Adoption of Exposure Notification Apps: Quantitative Study Based on COVID Alert.

Authors:  Kiemute Oyibo; Plinio Pelegrini Morita
Journal:  JMIR Form Res       Date:  2022-09-06

4.  Sociodemographic Differences and Factors Affecting Patient Portal Utilization.

Authors:  Martina A Clarke; Elizabeth R Lyden; Jihyun Ma; Keyonna M King; Mohammad Mo Siahpush; Tzeyu Michaud; Regina E Idoate; Athena K Ramos
Journal:  J Racial Ethn Health Disparities       Date:  2020-08-24

5.  Sustaining Patient Portal Continuous Use Intention and Enhancing Deep Structure Usage: Cognitive Dissonance Effects of Health Professional Encouragement and Security Concerns.

Authors:  Murad Moqbel; Barbara Hewitt; Fiona Fui-Hoon Nah; Rosann M McLean
Journal:  Inf Syst Front       Date:  2021-06-21       Impact factor: 6.191

6.  Patient Portals: Useful for Whom and for What? A Cross-Sectional Analysis of National Survey Data.

Authors:  Christine M Swoboda; Matthew J DePuccio; Naleef Fareed; Ann Scheck McAlearney; Daniel M Walker
Journal:  Appl Clin Inform       Date:  2021-07-07       Impact factor: 2.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.